TEL AVIV, Israel, April 3, 2017 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (CNBX) is pleased to announce that it received the final report of the research held in the Technion Israel Institute of Technology, in which the antitumor activity of cannabinoids was reflected in several...
April 04, 2017 at 02:27AM
http://ift.tt/2oCKsny
from
http://ift.tt/2oCKsny
No comments:
Post a Comment